Current stock page

Financial Data

KOD Financial Data

Revenue · Earnings · Margins · Balance Sheet · Cash Flow

HealthcareBiotechnologyScore data as of Nov 13, 2026

KODKodiak Sciences Inc.

Healthcare / Biotechnology

Relative Leader / Watch

Strong Relative Position

NeutralEdge 9/10
$111.19+$2.94 (+2.72%)

Latest quote

  • Momentum
    91
  • Value
    —
  • Quality
    9
  • Risk resilience
    44
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

Financial Data Overview

Detailed revenue, earnings, margins, balance sheet, cash flow, valuation metrics, technical indicators, and risk measures for deeper research.

Quarterly periods
8
Fundamental metrics
10
Technical indicators
12
Risk measures
6

Quarterly Financial Statements

Updated Nov 16, 2026.

Income statement
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Revenue$0$0$0$0$0$0$0$0
Gross Profit$0$0$0$0$0$0$0-$6.68M
Operating Income-$67.1M-$66.84M-$59.78M-$57.45M-$62.35M-$55.51M-$59.07M-$46.18M
Net Income-$66.22M-$65.64M-$58.16M-$56.74M-$61.46M-$54.31M-$57.46M-$44.11M
EPS-$1.05-$1.05-$0.94-$1.04-$1.16-$1.03-$1.09-$0.84
Cash flow statement
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Operating Cash Flow-$43.87M-$46.24M-$40.01M-$39.38M-$32.88M-$34.67M-$29.08M-$30.07M
Capital Expenditure-$1.98M-$352K-$942K-$43K-$60K-$133K-$270K-$124K
Free Cash Flow-$45.85M-$46.59M-$40.95M-$39.42M-$32.94M-$34.81M-$29.35M-$30.19M
Net Cash Provided By Operating Activities-$43.87M-$46.24M-$40.01M-$39.38M-$32.88M-$34.67M-$29.08M-$30.07M
Balance sheet
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Assets$209.41M$256.81M$306.01M$351.53M$218.07M$256.73M$297.91M$335.58M
Total Debt$46.56M$95.7M$155.99M$159.18M$62.2M$65.21M$67.64M$70.35M
Cash And Cash Equivalents$88.68M$125.9M$169.53M$209.86M$72.04M$104.17M$138.85M$168.07M
Total Liabilities$196.84M$195.72M$193.91M$194.15M$194.38M$186.44M$189.07M$185.29M
Total Stockholders Equity$12.57M$61.1M$112.1M$157.38M$23.69M$70.29M$108.84M$150.29M
Key financial metrics
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
P/E ratio————————
P/B ratio556.8440.9824.112.8942.16.471.911.07
P/S ratio————————
Debt To Equity3.71.571.391.012.630.930.620.47
Free Cash Flow Yield-2.47%-6.39%-5.48%-6.73%-12.76%-25.43%-51.70%-73.07%
Financial ratios
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
P/E ratio————————
P/B ratio556.8440.9824.112.8942.16.471.911.07
P/S ratio————————
Return On Equity-19.63%-3.96%-205.76%-146.12%-9.17%-284.29%-175.14%-117.25%
Debt To Equity3.71.571.391.012.630.930.620.47

Current Stock Metrics

Current fundamental, technical, and risk readings in one place.

Fundamental metrics
MetricValue
Pe-27.25x
Pb556.84x
EPS Growth Yoy9.48%
Gross Margin0.00%
Operating Margin0.00%
ROE-287.64%
ROIC-151.99%
Debt To Equity3.7
FCF Yield-2.47%

As of Nov 13, 2026

Technical indicators
MetricValue
Close$111.19
Volume972,263
RSI (14)68.87
MACD8.12
MACD signal7.88
MACD histogram0.24
ADX (14)34.32
SMA (50)$76.72
SMA (200)$45.93
ATR (14)$6.63
Historical volatility (annualized)65.88%
Volume (20-day average)856,830

As of Nov 13, 2026

Risk measures
MetricValue
Resilience score44/100
Beta0.15
Annual volatility205.61%
Max Drawdown-36.24%
Sharpe Ratio1.43
VaR (95%, 1-day)-6.87%

As of Nov 13, 2026

Detailed Metrics

Additional measures remain available here while the decision pages stay focused.

Additional fundamental metrics

No additional fundamental metrics are available.

Additional technical indicators

No additional technical indicators are available.

Additional risk measures

No additional risk measures are available.

KOD Financial Data FAQ

What is Kodiak Sciences Inc.'s revenue?

Kodiak Sciences Inc.'s revenue is one of the core financial data points for KOD. Use it with revenue growth, margins, and EPS to understand whether sales are translating into earnings power.

Is Kodiak Sciences Inc.'s revenue growing?

Revenue growth shows whether Kodiak Sciences Inc. is expanding from prior periods. Compare growth with margins and free cash flow because faster sales growth is more valuable when profitability holds up.

What is KOD's EPS?

KOD's EPS, or earnings per share, helps connect net income to each share. EPS should be compared with EPS growth, P/E ratio, and analyst expectations.

What is Kodiak Sciences Inc.'s net income?

Kodiak Sciences Inc.'s net income shows profit after costs, taxes, and other expenses. It should be read with revenue, operating margin, EPS, and free cash flow.

How much free cash flow does Kodiak Sciences Inc. generate?

Free cash flow shows how much cash Kodiak Sciences Inc. generates after capital spending. It is useful for judging reinvestment capacity, buybacks, debt reduction, and valuation support.

How much cash and debt does Kodiak Sciences Inc. have?

Cash and debt help frame KOD's balance-sheet flexibility. Compare liquidity and leverage with free cash flow and profitability before judging financial strength.